The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AbbVie Inc | COM | 00287Y109 | 3,831 | 52,681 | SH | SOLE | 52,681 | 0 | 0 | ||
| Allergan PLC | SHS | G0177J108 | 560 | 3,347 | SH | SOLE | 3,347 | 0 | 0 | ||
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | 4,465 | 230,295 | SH | SOLE | 230,295 | 0 | 0 | ||
| AnaptysBio Inc | COM | 032724106 | 679 | 12,026 | SH | SOLE | 12,026 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 6,940 | 60,266 | SH | SOLE | 60,266 | 0 | 0 | ||
| Biohaven Pharmaceutical Holdin | COM | G11196105 | 3,773 | 86,165 | SH | SOLE | 86,165 | 0 | 0 | ||
| Audentes Therapeutics Inc | COM | 05070R104 | 11,131 | 294,013 | SH | SOLE | 294,013 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 6,991 | 316,316 | SH | SOLE | 316,316 | 0 | 0 | ||
| Dermira Inc | COM | 24983L104 | 1,320 | 138,102 | SH | SOLE | 138,102 | 0 | 0 | ||
| Global Blood Therapeutics Inc | COM | 37890U108 | 7,485 | 142,305 | SH | SOLE | 142,305 | 0 | 0 | ||
| Gilead Sciences Inc | COM | 375558103 | 1,263 | 18,697 | SH | SOLE | 18,697 | 0 | 0 | ||
| Intercept Pharmaceuticals Inc | COM | 45845P108 | 12,130 | 152,441 | SH | SOLE | 152,441 | 0 | 0 | ||
| Immunomedics Inc | COM | 452907108 | 7,270 | 524,140 | SH | SOLE | 524,140 | 0 | 0 | ||
| Insmed Inc | COM PAR $.01 | 457669307 | 12,051 | 470,741 | SH | SOLE | 470,741 | 0 | 0 | ||
| Intra-Cellular Therapies Inc | COM | 46116X101 | 1,865 | 143,665 | SH | SOLE | 143,665 | 0 | 0 | ||
| Madrigal Pharmaceuticals Inc | COM | 558868105 | 1,616 | 15,423 | SH | SOLE | 15,423 | 0 | 0 | ||
| Mylan NV | SHS EURO | N59465109 | 1,953 | 102,560 | SH | SOLE | 102,560 | 0 | 0 | ||
| Neurocrine Biosciences Inc | COM | 64125C109 | 7,800 | 92,380 | SH | SOLE | 92,380 | 0 | 0 | ||
| Pacira BioSciences Inc | COM | 695127100 | 6,484 | 149,086 | SH | SOLE | 149,086 | 0 | 0 | ||
| uniQure NV | SHS | N90064101 | 4,680 | 59,883 | SH | SOLE | 59,883 | 0 | 0 | ||
| Regeneron Pharmaceuticals Inc | COM | 75886F107 | 1,774 | 5,668 | SH | SOLE | 5,668 | 0 | 0 | ||
| Sarepta Therapeutics Inc | COM | 803607100 | 7,646 | 50,317 | SH | SOLE | 50,317 | 0 | 0 | ||
| UroGen Pharma Ltd | COM | M96088105 | 6,357 | 176,866 | SH | SOLE | 176,866 | 0 | 0 | ||